Bitrobius Genetics

Early Stage

Bitrobius is a start-up biotechnology company developing a synthetic gene transfer technology for use in the research & development, manufacture and delivery of cell and gene therapies and vaccines.

Cell and gene therapy is an emerging and fast-growing area of biotechnology and drug development. Bitrobius has a very novel platform technology to increase the efficiency of gene transfer that could be applied to many areas of cell and gene therapy with multiple commercialisation routes.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Laurence Vaughan

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200